About Elucid
Elucid is a company based in Boston (United States) founded in 2013 by James Hamilton and Andrew J Buckler. Elucid has raised $151.87 million across 7 funding rounds from investors including Elevage Medical Technologies, MedTex Ventures and IAG Capital Partners. Elucid operates in a competitive market with competitors including Vista.ai, Circle Cardiovascular Imaging, Volta Medical, UltraSight and Us2.ai, among others.
- Headquarter Boston, United States
- Founders James Hamilton, Andrew J Buckler
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Elucid Bioimaging Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$151.87 M (USD)
in 7 rounds
-
Latest Funding Round
$36.5 M (USD), Series C
Oct 10, 2025
-
Investors
Elevage Medical Technologies
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Elucid
Unlock access to complete
Funding Insights of Elucid
Elucid has successfully raised a total of $151.87M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $36.5 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Elucid
Elucid has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Elevage Medical Technologies, MedTex Ventures and IAG Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture capital investments are provided by IAG Capital Partners.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Elucid
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Elucid
Investment portfolio details for Elucid
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Elucid
Detailed financials for Elucid
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Elucid Comparisons
Peer comparison for Elucid
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Elucid
Elucid operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vista.ai, Circle Cardiovascular Imaging, Volta Medical, UltraSight and Us2.ai, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-guided software is utilized to automate MRI exams for clinicians.
|
|
| Locked | Locked | Locked |
Software for cardiac MR and CT image evaluation is provided.
|
|
| Locked | Locked | Locked |
AI-based cardiac mapping assistance software is developed.
|
|
| Locked | Locked | Locked |
AI platform for ultrasound diagnosis of cardiac disorders is offered.
|
|
| Locked | Locked | Locked |
Heart risk is detected using AI-powered echocardiogram analysis.
|
Detailed competitors of Elucid
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Elucid
Complete news archive for Elucid
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elucid
Elucid was founded in 2013.
Elucid is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Blake Richards is the current CEO of Elucid.
Elucid is a funded company, having raised a total of $151.87M across 7 funding rounds to date.
Elucid was founded in 2013 and is headquartered in Boston, United States. AI-driven software for arterial analysis is provided to healthcare providers, supporting clinical diagnostic processes. Features are included for clinical research, personalized patient care, and stroke prediction. Operations focus on medical imaging and diagnostic tools within the health technology sector.
Elucid's top competitors include Vista.ai, Us2.ai and Volta Medical.
Elucid has 8 investors. Key investors include Elevage Medical Technologies, MedTex Ventures, IAG Capital Partners, BlueStone Venture Partners, and Biovision Ventures.